Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 5, 2018
Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to Shareholders
TEL AVIV, Israel, March 5, 2018 /PRNewswire/ --Kitov Pharmaceuticals (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that it filed its Annual Report ...
March 5, 2018
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
March 5, 2018
Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
March 1, 2018
Basilea names Adesh Kaul as new member of its Management Committee
Basel, Switzerland, March 01, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today that Adesh Kaul will join Basilea's Management Committee as Chief Corporate Development Officer ...
March 1, 2018
iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution
VIENNA, Austria, March 01, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global leader in medical technology providing innovative cancer detection and therapy solutions, today ...
March 1, 2018
BIOPHYTIS updates on SARA clinical study of Sarconeos in sarcopenia and presents four posters at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Miami
PARIS, March 01, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related diseases, ...
March 1, 2018
Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Remains on Track for Commercial Launch by First Quarter 2019
BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
March 1, 2018
CytoSorbents to Report Fiscal 2017 Operating and Financial Results
MONMOUTH JUNCTION, N.J., March 1, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill ...
March 1, 2018
Arena Pharmaceuticals to Present Phase 1 and Preclinical Data on APD371 in Development for Treatment of Pain Associated with Crohn's Disease at American Pain Society Annual Scientific Summit
SAN DIEGO, March 1, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), will present Phase 1 and preclinical data for the investigative drug candidate APD371 at the ...
March 1, 2018
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced operating and financial results for the fourth quarter and ...
March 1, 2018
Achaogen Enters Into New $50 Million Secured Credit Facility with Silicon Valley Bank
SOUTH SAN FRANCISCO, Calif., March 1, 2018 /PRNewswire/ -- Achaogen, Inc.(AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, has entered ...
February 28, 2018
Moberg Pharma Divests Balmex® for $4.25 Million
STOCKHOLM, Feb. 28, 2018 /PRNewswire/ --Moberg Pharma AB (OMX:MOB) has entered into an agreement with Randob Labs to divest the brand Balmex® for a total ...
February 28, 2018
BioTime to Present at the Raymond James 39th Annual Institutional Investor Conference
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Russell Skibsted, Chief ...
February 28, 2018
Heat Biologics Announces Positive Interim Data from its Phase 2 Clinical Trial of HS-110 and Nivolumab in Non-Small Cell Lung Cancer (NSCLC)
DURHAM, NC / ACCESSWIRE / February 28, 2018 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system ...
February 28, 2018
Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
REHOVOT, Israel, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company focused on ...
February 28, 2018
Vermillion to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, March 13
AUSTIN, Texas, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report ...
February 28, 2018
AzurRx BioPharma to Present at the 30th Annual ROTH Conference (March 12th)
BROOKLYN, N.Y., Feb. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant ...
February 28, 2018
Rockwell Medical Announces Triferic Presentations at the 2018 Annual Dialysis Conference
WIXOM, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), announced today that two Triferic abstracts have been selected for presentation at the ...
February 28, 2018
Genkyotex Announces 2017 Annual Financial Results
Genkyotex (GKTX.PA) (GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announces its consolidated financial results for ...
February 28, 2018
OSE Immunotherapeutics Presenting at the Annual International Conference BIO-EUROPE SPRING®
NANTES, France, Feb. 28, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics(ISIN:FR0012127173) (Mnémo:OSE), announces it will be featured as a presenting company at the 12th Annual Conference BIO-EUROPE ...
Page 62 of 117